ArticleJournal of cellular and molecular medicine2022

A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.

Michelle Zalles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.